Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

Conditions:   NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients;   Synovial Sarcoma;   Melanoma;   Esophageal Cancer;   Ovarian Cancer;   Lung Cancer;   Bladder Cancer;   Liver Cancer
Interventions:   Drug: Cyclophosphamide;   Biological: TBI-1301
Sponsors:   University Health Network, Toronto;   Takara Bio Inc.
Not yet recruiting - verified August 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/2b60AsN
via IFTTT